2016
Opened business in the U.S.
We are able to deliver high quality results efficiently and at a competitive price. Our team of experienced scientists, engineers, and technicians work together to provide innovative solutions for clients in the pharmaceutical business and research. Our laboratories are equipped with the latest technology and equipment, allowing us to perform a wide range of analytical tests with accuracy and precision. By owning our laboratories, we have full control over the quality and timeliness of our results, making sure that our clients receive reliable and trustworthy results every time. In addition, our laboratories overseas allow us to cut costs on R&D without loosing quality and provide us the access to biomaterial, which is more scarce in the U.S. (fresh tumor tissue).
Highly accomplished and passionate leader with 20 years of experience. Expertise in expanding market share, establishing international distribution networks, and driving significant revenue growth.Experience as Business Unit Manager at Merck and Solvay Pharmaceuticals (owned by Abbott), as well as experience at Boehringer Ingelheim.
Research scientist with 10+ years of experience in academia and industry, specializing in signaling aberrations in tumors and their microenvironment. Certified in GCP, GLP, and drug development. 15 first-author publications in top-tier scientific journals, and established partnerships with academia, biotech, and the pharmaceutical industry.
Tetiana has 8 years of project management and consulting experience. Devised and implemented corporate, marketing, and functional strategies for fast-growing small and mid-sized companies in various industries. Expertise in revenue acceleration, partnership development, client relations, and strategy ideation.
We are a clinical research organization, which provides a variety of well-characterized biomaterials for pharmaceutical companies and research organizations, including tissue samples, cell lines, and 3D models of the tumor.
Customizable solutions for clinical trials using 3D models.
Access to a large pool of biosamples, including cell lines and organoids.
Full control over product cycle: from sample collection to delivery to the client.
Faster and more efficient clinical trials using subjects with brain death.
Reliable network of labs in America and Europe for processing, testing, and quality control.
Comprehensive network of human biospecimen collection sites from North America, Europe, Asia, and Africa.
